p53 and Bax protein expression as predictor of chemotherapeutic effect in gastric carcinoma

Gan to kagaku ryoho. Cancer & chemotherapy

Volumn 25 Suppl 3, Issue , 1998, Pages 400-403

  Muguruma, K ^a   Nakata, B ^a   Hirakawa, K ^a   Yamashita, Y ^a   Onoda, N ^a   Inoue, T ^a   Matsuoka, T ^a   Kato, Y ^a   Sowa, M ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BAX PROTEIN, HUMAN; CF REGIMEN; CISPLATIN; FLUOROURACIL; ONCOPROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ADENOCARCINOMA; AGED; APOPTOSIS; ARTICLE; CHEMISTRY; DRUG ADMINISTRATION; DRUG EFFECT; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; SIGNET RING CARCINOMA; STOMACH TUMOR;

ADENOCARCINOMA; ADENOCARCINOMA, PAPILLARY; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, SIGNET RING CELL; CISPLATIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032044511     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)